11/19/2024 5:26 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 5:26 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 5:26 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 5:26 PM | Mauro David J (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2024 5:52 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 6:19 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 6:19 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/13/2024 3:34 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024 9:11 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024 8:22 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 3:57 PM | Recursion Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024 1:48 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024 9:34 AM | FMR LLC (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024 1:17 PM | BlackRock, Inc. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024 3:18 PM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 5:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 5:12 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
11/04/2024 3:16 PM | Kinnevik AB (0001766574) (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024 12:27 PM | Recursion Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 8:46 AM | BAILLIE GIFFORD & CO (Filed by) Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/31/2024 5:01 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/30/2024 4:20 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
10/29/2024 3:35 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024 4:25 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2024 3:22 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024 2:24 PM | BlackRock, Inc. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/18/2024 9:59 AM | Recursion Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024 4:27 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2024 4:15 PM | Burrell Terry-Ann (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 3:42 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 5:40 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2024 5:00 AM | Recursion Pharmaceuticals (Filer)
| Form DEFM14A | |
10/09/2024 3:23 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 3:19 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024 5:29 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 5:30 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 5:30 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 5:30 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:58 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 9:27 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024 12:31 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
10/02/2024 7:03 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 1:20 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024 5:15 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2024 3:14 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024 4:48 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:27 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/17/2024 5:03 AM | Recursion Pharmaceuticals (Filer)
| Form PREM14A | |
09/12/2024 5:28 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 4:15 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 4:00 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 3:57 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 4:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 10:43 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 4:24 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/04/2024 12:16 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 3:48 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:27 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 7:02 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/30/2024 3:26 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:53 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 3:49 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/27/2024 3:10 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:42 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:25 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 5:48 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 6:09 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:09 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:09 PM | Mauro David J (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:09 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:24 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:35 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 3:22 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024 3:19 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/08/2024 4:23 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 11:56 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024 7:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 7:09 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 7:10 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/07/2024 12:34 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024 3:50 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024 5:16 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 5:15 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:37 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024 3:17 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 5:52 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4/A | |
07/12/2024 5:54 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:51 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:51 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
07/11/2024 9:38 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 3:41 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 11:56 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:30 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2024 3:17 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
07/03/2024 3:39 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 3:39 PM | Burrell Terry-Ann (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 3:39 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |